Combination Methods for Screening Marine Actinomycetes Producing Potential Compounds as Anticancer

Marine actinomycetes is a robust source of secondary metabolites including anticancer compounds . The objective of this research was to select marine actinomycetes producing potential compounds as anticancer used combination methods that consist of amplification PKS I (polyketide synthases type I) a...

Full description

Bibliographic Details
Main Authors: Yuyun Farida, Jaka Widada, Edy Meiyanto
Format: Article
Language:English
Published: Universitas Gadjah Mada, Yogyakarta 2015-11-01
Series:Indonesian Journal of Biotechnology
Online Access:http://journal.ugm.ac.id/ijbiotech/article/view/7772
id doaj-ed5edbdb808b4c9cac1a617a107e63f3
record_format Article
spelling doaj-ed5edbdb808b4c9cac1a617a107e63f32020-11-25T00:38:30ZengUniversitas Gadjah Mada, YogyakartaIndonesian Journal of Biotechnology0853-86542089-22412015-11-011226499Combination Methods for Screening Marine Actinomycetes Producing Potential Compounds as AnticancerYuyun FaridaJaka WidadaEdy MeiyantoMarine actinomycetes is a robust source of secondary metabolites including anticancer compounds . The objective of this research was to select marine actinomycetes producing potential compounds as anticancer used combination methods that consist of amplification PKS I (polyketide synthases type I) and NRPS (non ribosomal peptide synthetases) genes, analysis the diversity of secondary metabolites and genetic. Selected isolates were used for cytotoxicity assay. PKS I and NRPS genes were amplified using sets of degenerate primers. K1F and M6R were used for amplify ketosynthase and methyl-malonyl-CoA transferase modules of PKS I gene which targeted sequences 1200-1400 bp. A3F and A7R were used for amplify adenilation domains of NRPS gene which targeted sequences 700-800 bp. The diversity of secondary metabolites was analized by TLC and densitometry of ethyl acetate extracts. Genetic diversity was analized by repetitive DNA fingerprinting using BOXA1R primers. The cytotoxicity of secondary metabolites on T47D and MCF7 breast cell lines cancer was measured by MTT assay method. Fifty two marine actinomycetes isolates were screened using combination methods. Ten isolates were detected encoding both PKS I and NRPS genes, whereas 11 isolates were detected encoding the NRPS gene. The screening by analysis of secondary metabolites and genetic diversity methods were obtained 6 selected isolates for cytotoxicity assay, which consist of 3 isolates encoding both PKS I and NRPS genes and 3 isolates encoding NRPS gene.Isolate 1 had high cytotoxicity with the IC50 on T47D cell was 19 μg/ml and the IC50 on MCF7 cell was 7 g/ml. This findings suggests that combination methods were effective and efficient way to select marine actinomycetes producing potential compounds as anticancer.http://journal.ugm.ac.id/ijbiotech/article/view/7772
collection DOAJ
language English
format Article
sources DOAJ
author Yuyun Farida
Jaka Widada
Edy Meiyanto
spellingShingle Yuyun Farida
Jaka Widada
Edy Meiyanto
Combination Methods for Screening Marine Actinomycetes Producing Potential Compounds as Anticancer
Indonesian Journal of Biotechnology
author_facet Yuyun Farida
Jaka Widada
Edy Meiyanto
author_sort Yuyun Farida
title Combination Methods for Screening Marine Actinomycetes Producing Potential Compounds as Anticancer
title_short Combination Methods for Screening Marine Actinomycetes Producing Potential Compounds as Anticancer
title_full Combination Methods for Screening Marine Actinomycetes Producing Potential Compounds as Anticancer
title_fullStr Combination Methods for Screening Marine Actinomycetes Producing Potential Compounds as Anticancer
title_full_unstemmed Combination Methods for Screening Marine Actinomycetes Producing Potential Compounds as Anticancer
title_sort combination methods for screening marine actinomycetes producing potential compounds as anticancer
publisher Universitas Gadjah Mada, Yogyakarta
series Indonesian Journal of Biotechnology
issn 0853-8654
2089-2241
publishDate 2015-11-01
description Marine actinomycetes is a robust source of secondary metabolites including anticancer compounds . The objective of this research was to select marine actinomycetes producing potential compounds as anticancer used combination methods that consist of amplification PKS I (polyketide synthases type I) and NRPS (non ribosomal peptide synthetases) genes, analysis the diversity of secondary metabolites and genetic. Selected isolates were used for cytotoxicity assay. PKS I and NRPS genes were amplified using sets of degenerate primers. K1F and M6R were used for amplify ketosynthase and methyl-malonyl-CoA transferase modules of PKS I gene which targeted sequences 1200-1400 bp. A3F and A7R were used for amplify adenilation domains of NRPS gene which targeted sequences 700-800 bp. The diversity of secondary metabolites was analized by TLC and densitometry of ethyl acetate extracts. Genetic diversity was analized by repetitive DNA fingerprinting using BOXA1R primers. The cytotoxicity of secondary metabolites on T47D and MCF7 breast cell lines cancer was measured by MTT assay method. Fifty two marine actinomycetes isolates were screened using combination methods. Ten isolates were detected encoding both PKS I and NRPS genes, whereas 11 isolates were detected encoding the NRPS gene. The screening by analysis of secondary metabolites and genetic diversity methods were obtained 6 selected isolates for cytotoxicity assay, which consist of 3 isolates encoding both PKS I and NRPS genes and 3 isolates encoding NRPS gene.Isolate 1 had high cytotoxicity with the IC50 on T47D cell was 19 μg/ml and the IC50 on MCF7 cell was 7 g/ml. This findings suggests that combination methods were effective and efficient way to select marine actinomycetes producing potential compounds as anticancer.
url http://journal.ugm.ac.id/ijbiotech/article/view/7772
work_keys_str_mv AT yuyunfarida combinationmethodsforscreeningmarineactinomycetesproducingpotentialcompoundsasanticancer
AT jakawidada combinationmethodsforscreeningmarineactinomycetesproducingpotentialcompoundsasanticancer
AT edymeiyanto combinationmethodsforscreeningmarineactinomycetesproducingpotentialcompoundsasanticancer
_version_ 1725297226195927040